4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-20-001767
PRES./CHIEF SCIENTIFIC OFFICER acquired 5,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2020-06-30 | Grant or award | +5,000 | $0.45 | $2,240 | 67,724 | D |
Loading xslF345X03/form4-07012020_020710.xml…